NEW YORK (GenomeWeb News) – Invitrogen said today that it has created a new business unit that is focused on the cell therapy market.
The Carlsbad, Calif.-based firm said the new Cell Therapy Systems business would integrate relevant technologies, such as Dynal magnetic beads for cell isolation, Gibco cell expansion media, and Molecular Probes cell characterization tools.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.